UK's NHS model "should be abandoned"

24 September 2006

The UK's National Health Service, which provides most health care services free at the point of delivery and includes a flat-rate charge for prescription drugs, should be replaced by a more consumer-orientated co-payer system, according to the UK's oldest free-market think-tank, the London-based Institute of Economic Affairs.

A study published by the IEA, titled Pharmaceuticals and Government Policy, argues that consumers should take more responsibility in the fields of health care and drugs. Tony Hockley, who authored the report, found that, in many areas of UK health care, producers rather than consumers dictate the allocation of resources. Mr Hockley said: "health care systems worldwide are facing important challenges, as their users change from being passive recipients of services determined by third parties to active and interested consumers."

According to the IEA, the UK's NHS has resulted in British innovations in, for example, hip replacements, new forms of leg ulcer treatments and palliative care being applied across the globe but often denied to British patients.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight